Well, with a long history as an ex-McKinsey & Co. China-based health care guru, Dr. Yehong Zhang (at right, in 2011) has all the proper pedigree for a multinational’s leading man in China. And China for Merck, as we’ve previously noted, circa late 2011 — might be as much as 25 per cent of all of Merck’s revenue growth (come 2014). It is, in short, an extremely important emerging growth market.
Problem is, MSD China, via Simcere. . . no longer has him. He was the President of the operation there. He’s been recruited away to Aetna, as President, China. That’s bad news for Merck. Here’s a link to the MenaFN.com press story — and a bit:
So it goes. . .